Inspire Medical Systems, Inc. (INSP)

Inspire Medical Systems Stock Forecast

Stock Price Forecast

The 12 analysts that cover Inspire Medical Systems stock have a consensus rating of "Buy" and an average price target of $213.75, which forecasts a 65.08% increase in the stock price over the next year. The lowest target is $174 and the highest is $255.

Price Target: $213.75 (+65.08%)

Analyst Consensus: Buy

Target	Low	Average	Median	High
Price	$174	$213.75	$216	$255
Change	+34.38%	+65.08%	+66.82%	+96.94%

* Price targets were last updated on May 6, 2025.

Analyst Ratings

The average analyst rating for Inspire Medical Systems stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Rating	Jan '25	Feb '25	Mar '25	Apr '25	May '25	Jun '25
Strong Buy	3	3	3	2	2	2
Buy	5	5	5	6	7	7
Hold	3	3	3	3	3	3
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	11	11	11	11	12	12

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Kallum Titchmarsh Morgan Stanley	Morgan Stanley	Buy Maintains $220 → $200	Buy	Maintains	$220 → $200	+54.46%	May 6, 2025
Robbie Marcus JP Morgan	JP Morgan	Buy Maintains $235 → $195	Buy	Maintains	$235 → $195	+50.60%	May 6, 2025
Larry Biegelsen Wells Fargo	Wells Fargo	Hold Maintains $195 → $174	Hold	Maintains	$195 → $174	+34.38%	May 6, 2025
Mike Polark Baird	Baird	Buy Maintains $230 → $236	Buy	Maintains	$230 → $236	+82.27%	May 6, 2025
Jonathan Block Stifel	Stifel	Hold Maintains $190 → $175	Hold	Maintains	$190 → $175	+35.16%	Apr 21, 2025

More Analyst Ratings

Financial Forecast

Revenue This Year

968.30M

Increased by 20.61%

from 802.80M

Revenue Next Year

1.14B

Increased by 17.32%

from 968.30M

EPS This Year

2.31

Increased by 32.12%

from 1.75

EPS Next Year

3.30

Increased by 42.74%

from 2.31

Fiscal Year	FY 2020	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026	FY 2027
Period Ending	Dec 31, 2020	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026	Dec 31, 2027
Revenue	115.38M	233.39M	407.86M	624.80M	802.80M	968.30M	1.14B	1.32B
Revenue Growth	40.62%	102.28%	74.75%	53.19%	28.49%	20.61%	17.32%	16.37%
EPS	-2.19	-1.54	-1.60	-0.72	1.75	2.31	3.30	4.60
EPS Growth	-	-	-	-	-	32.12%	42.74%	39.28%
Forward PE	-	-	-	-	-	56.00	39.23	28.17
No. Analysts	-	-	-	-	-	21	21	14

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2025	2026	2027	2028	2029
High	1.0B	1.2B	1.4B
Avg	968.3M	1.1B	1.3B
Low	921.2M	1.1B	1.2B

Revenue Growth

Revenue Growth	2025	2026	2027	2028	2029
High	24.8%	23.4%	24.3%
Avg	20.6%	17.3%	16.4%
Low	14.7%	10.2%	6.4%

EPS Forecast

EPS	2025	2026	2027	2028	2029
High	2.52	3.90	5.93
Avg	2.31	3.30	4.60
Low	2.16	2.76	3.79

EPS Growth

EPS Growth	2025	2026	2027	2028	2029
High	44.0%	68.5%	79.8%
Avg	32.1%	42.7%	39.3%
Low	23.2%	19.5%	14.9%

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.